2.Analysis for dropout of DTaP routine immunization in China in 2019.
Jia Kai YE ; Lei CAO ; Wen Zhou YU ; Yi Fan SONG ; Zun Dong YIN
Chinese Journal of Preventive Medicine 2022;56(12):1723-1727
Objective: To analyze the dropout of adsorbed diphtheria, tetanus and acellular pertussis combined vaccine (DTaP) routine immunization in China in 2019. Methods: DTaP vaccination data in all counties in China were collected through National Immunization Program Information Management System in 2019. Cumulative dropout rate and vaccination rate of DTaP in different provinces were calculated. According to the P25, P50 and P75 values of DTaP dropout rate for all counties by province, counties in each province were divided into four groups (Q1-Q4). The DTaP average dropout rate of four groups and absolute difference (difference in DTaP average dropout rate between Q4 and Q1) were calculated. Spearman rank correlation was used to analyze the relationship between absolute difference and provincial DTaP dropout rate, DTaP1 and DTaP3 vaccination rate. Results: DTaP1 vaccination rate ranged from 92.98% to 99.94% by province, with a median of 99.55%. Provincial DTaP dropout rate ranged from 0.36% to 28.66%, with a median of 3.54%. The provincial DTaP dropout rate was more than 10% in Gansu and Guizhou, about 28.66% and 17.19%. Absolute difference ranged from 4.02% to 39.22%, with a median of 10.16%. Provinces with the largest absolute difference were Gansu, Qinghai, Liaoning and Guizhou, about 39.22%, 34.48%, 23.31% and 21.33%, respectively. Correlation analysis indicated that the absolute difference was positively correlated with provincial DTaP dropout rate, with a correlation coefficient of 0.492 (P=0.004). It was negatively correlated with DTaP1 and DTaP3 vaccination rate. Correlation coefficients were -0.542 (P=0.001) and -0.562 (P=0.001), respectively. Conclusions: There are significant county-level differences in DTap dropout rate in most provinces, with relatively high difference in western provinces.
Humans
;
Infant
;
Whooping Cough/prevention & control*
;
Diphtheria-Tetanus-Pertussis Vaccine
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Vaccination
;
China
;
Immunization, Secondary
;
Immunization Schedule
;
Antibodies, Bacterial
3.A survey of the domestic epidemiological characteristics and clinical manifestations of pertussis
Seock Hwa YOON ; Yong Hee HONG ; Hee Kyung LEE ; Jong Hyun LEE ; Meeyong SHIN
Allergy, Asthma & Respiratory Disease 2018;6(1):54-61
PURPOSE: This report describes the results of a survey of the characteristics of pertussis in children from a single institution and compares it to data from the Korea Centers of Disease Control (KCDC). METHODS: We retrospectively evaluated the medical records of 17 and 6 patients diagnosed with pertussis and parapertussis, respectively, at Soonchunhyang University Bucheon Hospital from January 2005 to January 2017. RESULTS: Of the 17 patients with pertussis, 9 were under 1 year of age (52.9%), 3 were aged between 1 and 10 years (17.6%), and 5 were over 10 years of age (29.4%). Seven patients (41.2%) had never received diphtheria-tetanus-acellular pertussis vaccines, of which 5 were infants below 2 months of age and 2 were 10 years old and lived in China. Four patients showed the initial symptoms of cough in China. The sources of infection were the parents (2 cases) and the siblings (8 cases). All patients showed prolonged severe cough and the average duration of cough was 26 days. Severe symptoms, including dyspnea, cyanosis, apnea, and seizures, were observed in the children under 2 months of age. According to the recent 10-year KCDC data, the highest rate of pertussis diagnosis was noted in infants (47.8%), followed by adolescents (18.7%). Six patients with parapertussis also presented with prolonged severe cough without any other severe symptoms. Lymphocytosis was not found, unlike the patients with pertussis. CONCLUSION: The possibility of pertussis and parapertussis should be considered among patients with prolonged severe cough, especially in infants and adolescents.
Adolescent
;
Apnea
;
Bordetella parapertussis
;
Bordetella pertussis
;
Child
;
China
;
Cough
;
Cyanosis
;
Diagnosis
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Dyspnea
;
Gyeonggi-do
;
Humans
;
Infant
;
Korea
;
Lymphocytosis
;
Medical Records
;
Parents
;
Retrospective Studies
;
Seizures
;
Siblings
;
Whooping Cough
4.Tetanus–diphtheria–acellular pertussis vaccination for adults: an update.
Clinical and Experimental Vaccine Research 2017;6(1):22-30
Although tetanus and diphtheria have become rare in developed countries, pertussis is still endemic in some developed countries. These are vaccine-preventable diseases and vaccination for adults is important to prevent the outbreak of disease. Strategies for tetanus, diphtheria, and pertussis vaccines vary from country to country. Each country needs to monitor consistently epidemiology of the diseases and changes vaccination policies accordingly. Recent studies showed that tetanus–diphtheria–acellular pertussis vaccine for adults is effective and safe to prevent pertussis disease in infants. However, vaccine coverage still remains low than expected and seroprevalence of protective antibodies levels for tetanus, diphtheria, and pertussis decline with aging. The importance of tetanus–diphtheria–acellular pertussis vaccine administration should be emphasized for the protection of young adult and elderly people also, not limited to children.
Adult*
;
Aged
;
Aging
;
Antibodies
;
Child
;
Developed Countries
;
Diphtheria
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Epidemiology
;
Humans
;
Infant
;
Pertussis Vaccine
;
Seroepidemiologic Studies
;
Tetanus
;
Vaccination*
;
Vaccines
;
Whooping Cough*
;
Young Adult
5.Investigation of Children with No Vaccinations Recorded on the National Immunization Registry Information System.
Ho Jin NAM ; Sok Goo LEE ; So Youn JEON ; Ji Eun OM ; Kwang Suk PARK
Journal of the Korean Society of Maternal and Child Health 2017;21(3):176-181
PURPOSE: To improve the quality of the vaccination program, analyze the cause and identify the influencing factors for not being registered in the National Immunization Registry Information System even once. METHODS: We conducted one-on-one household visit interview surveys after, using a list supplemented with addresses from the Ministry of the Interior. We identified the basic respondent information, information on relevant children (those born in 2012), the reasons for omission from computerized vaccination registration, and the actual residence of the registered children. RESULTS: The total number of unvaccinated children born in 2012 was 1,870. The final contact result of the household surveys was 1,254 successful contacts, 51 refused to be interviewed, and 565 were not found. The reason for missed vaccination registration was 928 cases of long-term stay overseas, 241 cases of missing registration owing to intentional refusal of vaccination, and 57 cases of illness. A comparison of complete vaccination rates between non-registrants and those of computerized registrants revealed rates of 17.9% and 96.3% for the 3 doses hepatitis B vaccine, 14.9% and 95.6% for the 4doses DTaP vaccine, 16.1% and 97.4% for the 3 doses polio vaccine, and 3.9% and 92.5% for the 3 (or 2) doses Japanese encephalitis vaccine, respectively. CONCLUSION: Vaccination is the most effective national health policy and one of the most remarkable accomplishments in medical history. Through great effort, Korea has started to transcribe vaccination records since 2000, and the records are now reaching a considerable level. However, there is an unregistered population of around 0.3%. Several measures can be taken to improve the registration rate in the vaccination records, such as managing non-registrants through education and interviews, and sharing vaccination data with foreign countries. The non-registrant management plan should include periodically compiling a list of children who are not registered in the National Immunization Registry Information System, conducting of household visits using survey forms, and data analysis to establish appropriate measures.
Child*
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Education
;
Encephalitis, Japanese
;
Family Characteristics
;
Health Policy
;
Hepatitis B Vaccines
;
Humans
;
Immunization*
;
Information Systems*
;
Korea
;
Poliomyelitis
;
Statistics as Topic
;
Surveys and Questionnaires
;
Vaccination*
6.Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age.
Hyun Sun KO ; Yun Seong JO ; Yeun Hee KIM ; Yong Gyu PARK ; Jeong Ha WIE ; Juyoung CHEON ; Hee Bong MOON ; Young LEE ; Jong Chul SHIN
Yonsei Medical Journal 2015;56(4):1071-1078
PURPOSE: The adult tetanus, reduced diphtheria, and acellular pertussis (Tdap) vaccine has been introduced in order to provide individual protection and reduce the risk of transmitting pertussis to infants. We assessed the knowledge and acceptability of the Tdap vaccine around pregnancy. MATERIALS AND METHODS: This study was a cross-sectional survey of women of childbearing age (20-45 years) who visited obstetrics and gynecologic units of primary, secondary, or tertiary hospitals. They were asked to fill in a questionnaire assessing their knowledge, attitudes, and acceptability of Tdap. RESULTS: The questionnaire was completed by 308 women; 293 (95.1%) had not received information from doctors about Tdap, and 250 (81.2%) did not know about the need for vaccination. A significantly important factor related to subjects' intention to be vaccinated, identified by stepwise multiple logistic regression, was the knowledge (OR 13.5, CI 3.92-46.33) that adult Tdap is effective in preventing pertussis for infants aged 0-6 months. Additionally, 276 (89.6%) considered the recommendation of obstetric doctors as the most influencing factor about Tdap vaccination. CONCLUSION: In Korea, most women of childbearing age seem to be neither recommended nor adequately informed about the vaccination, although our population was not a nationwide representative sample. Information given by healthcare workers may be critical for improving awareness and preventing pertussis.
Adult
;
Cross-Sectional Studies
;
Diphtheria
;
Diphtheria-Tetanus-acellular Pertussis Vaccines/*administration & dosage
;
Female
;
Health Knowledge, Attitudes, Practice/*ethnology
;
Humans
;
Immunization/*statistics & numerical data
;
Infant
;
Logistic Models
;
Multivariate Analysis
;
Patient Acceptance of Health Care/*ethnology/statistics & numerical data
;
Pregnancy
;
Republic of Korea/epidemiology
;
Risk
;
Surveys and Questionnaires
;
Tetanus
;
Vaccination
;
Whooping Cough/diagnosis/ethnology
7.Assessment of Serologic Immunity to Diphtheria-Tetanus-Pertussis After Treatment of Korean Pediatric Hematology and Oncology Patients.
Hyo Jin KWON ; Jae Wook LEE ; Nak Gyun CHUNG ; Bin CHO ; Hack Ki KIM ; Jin Han KANG
Journal of Korean Medical Science 2012;27(1):78-83
The aim of this study was to investigate the diphtheria-tetanus-pertussis antibody titers after antineoplastic treatment and to suggest an appropriate vaccination approach for pediatric hemato-oncologic patients. A total of 146 children with either malignancy in remission after cessation of therapy or bone marrow failure were recruited. All children had received routine immunization including diphtheria-tetanus-acellular pertussis vaccination before diagnosis of cancer. The serologic immunity to diphtheria, tetanus and pertussis was classified as: completely protective, partially protective, or non-protective. Non-protective serum antibody titer for diphtheria, tetanus and pertussis was detected in 6.2%, 11.6%, and 62.3% of patients, respectively, and partial protective serum antibody titer for diphtheria, tetanus and pertussis was seen in 37%, 28.1%, and 8.9% of patients. There was no significant correlation between the severity of immune defect and age, gender or underlying disease. Revaccination after antineoplastic therapy showed significantly higher levels of antibody for each vaccine antigen. Our data indicates that a large proportion of children lacked protective serum concentrations of antibodies against diphtheria, tetanus, and pertussis. This suggests that reimmunization of these patients is necessary after completion of antineoplastic treatment. Also, prospective studies should be undertaken with the aim of devising a common strategy of revaccination.
Adolescent
;
Age Factors
;
Antibodies, Bacterial/blood/immunology
;
Antineoplastic Agents/therapeutic use
;
Child
;
Child, Preschool
;
Diphtheria/immunology/prevention & control
;
Diphtheria-Tetanus-acellular Pertussis Vaccines/*immunology
;
Female
;
Hematologic Neoplasms/*diagnosis/drug therapy
;
Humans
;
Immunization, Secondary
;
Lymphoma/diagnosis/drug therapy
;
Male
;
Neuroblastoma/diagnosis/drug therapy
;
Sex Factors
;
Tetanus/immunology/prevention & control
;
Whooping Cough/immunology/prevention & control
8.Infant Pertussis and Household Transmission in Korea.
Hyo Jin KWON ; Sook Kyung YUM ; Ui Yoon CHOI ; Soo Young LEE ; Jong Hyun KIM ; Jin Han KANG
Journal of Korean Medical Science 2012;27(12):1547-1551
A recent resurgence of pertussis has raised public health concerns even in developed countries with high vaccination coverage. The aim of this study was to describe the clinical characteristics of infant pertussis, and to determine the relative importance of household transmission in Korea. The multicenter study was prospectively conducted from January 2009 to September 2011. We identified the demographic and clinical data from these patients and performed the diagnostic tests for pertussis in their household contacts. Twenty-one patients with confirmed pertussis were included in the analysis. All infections occurred in infants younger than 6 months of age (mean age, 2.5 months) who had not completed the primary DTaP vaccination except for one patient. Infants without immunization history had a significant higher lymphocytosis and longer duration of hospital stay compared to those with immunization. All were diagnosed with PCR (100%), however, culture tests showed the lowest sensitivity (42.9%). Presumed source of infection in household contacts was documented in 85.7%, mainly parents (52.6%). Pertussis had a major morbidity in young infants who were not fully immunized. Household members were responsible for pertussis transmission of infants in whom a source could be identified. The control of pertussis through booster vaccination with Tdap in family who is taking care of young infants is necessary in Korea.
Bordetella pertussis/genetics
;
Diphtheria-Tetanus-acellular Pertussis Vaccines/immunology
;
Female
;
Humans
;
Immunization, Secondary
;
Infant
;
Length of Stay
;
Lymphocytosis/etiology
;
Male
;
Parents
;
Polymerase Chain Reaction
;
Prospective Studies
;
Republic of Korea
;
Whooping Cough/diagnosis/immunology/*transmission
9.Immunogenicity and safety of primary and secondary DTaP booster vaccination.
Ui Yoon CHOI ; Soo Young LEE ; Ga Young KWAK ; Sang Hyuk MA ; Joon Su PARK ; Hwang Min KIM ; Jin Han KANG
Journal of the Korean Medical Association 2011;54(9):979-987
Diphtheria-tetanus-acellular pertussis (DTaP) vaccination must currently be administered three times starting at 2 months of age, at intervals of two months, with the first and second boosters administered at 15 to 8 months and 4 to 6 years of age. A high rate of vaccination is maintained, but studies of the efficiency and safety of booster vaccination are lacking. This study evaluated the immunogenicity and safety of the DTaP booster vaccine. Seventy-two infants who had been vaccinated with the first booster and 78 children who had been vaccinated with the second booster were enrolled in this study. Local and systemic adverse reactions after vaccination were recorded. Sera obtained before and 1 month after booster vaccination were analyzed for antibodies to diphtheria and tetanus toxoid, and anti-pertussis toxin. Diphtheria: The GMT was increased. Tetanus: The geometric mean antibody titer (GMT) was increased. Pertussis: The GMT was increased by 13.72 times and 14.37 times after the first and the second additional vaccination, respectively. Although the seroconversion rate was low prior to the first booster, the average amount of anti-pertussis toxin antibodies before the first additional vaccination was 143.37 EU/mL, which rose to 261.88 EU/mL after the vaccination. The seroconversion rate also increased to 100%. Adverse reactions showed spontaneous resolution within a few days after vaccination. After the second additional vaccination, there was a statistically significant increase in the manifestation of myalgia compared to after the first additional vaccination. In conclusion, DTaP booster vaccination was effective in Korean children, demonstrating that modifications to the current regimen would be unnecessary.
Antibodies
;
Child
;
Diphtheria
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Humans
;
Immunization, Secondary
;
Infant
;
Tetanus Toxoid
;
Vaccination
;
Whooping Cough

Result Analysis
Print
Save
E-mail